Cortisol Against DHEA-S: A Catabolic-vs-Anabolic Adrenal Snapshot
Cortisol-to-DHEA-S ratio blood testing compares two adrenal hormones in your bloodstream. Cortisol is the body's primary stress hormone, made in the adrenal cortex's middle layer (zona fasciculata) in response to adrenocorticotropic hormone (ACTH). DHEA-S is the stable, circulating form of DHEA (dehydroepiandrosterone sulfate), produced mainly in the inner layer (zona reticularis). These small glands sit atop the kidneys; the ratio expresses cortisol relative to DHEA-S to show their relationship.
This ratio reflects the balance between stress-response output and recovery/rebuilding capacity (catabolic versus anabolic/anti-stress signaling) within the hypothalamic–pituitary–adrenal axis (HPA). Cortisol mobilizes energy; DHEA-S buffers that response and supports maintenance and adaptation. Considering the ratio, rather than either hormone alone, reveals how adrenal output is weighted at a given time—toward immediate demand or long-term resilience—providing an integrated view of stress biology.
How Adrenal Balance Shapes Whole-Body Resilience
The cortisol-to-DHEA-S ratio shows how your adrenal glands balance "breakdown" and "build-and-repair." Cortisol mobilizes fuel and sets the body's stress response; DHEA-S is a stable, androgenic precursor that supports resilience, muscle, bone, mood, and immunity. The ratio integrates brain–adrenal signals with metabolic and immune tone, so it reflects whole‑body stress biology rather than a single hormone in isolation. Cortisol drives energy mobilization, blood pressure, and inflammation control (catabolic). DHEA-S supports tissue repair, neurocognition, and sex-hormone balance (anabolic/androgenic).
Big picture: this ratio anchors the HPA axis to metabolism, immunity, brain function, and reproductive health. Persistently unbalanced values—especially trending high—are associated with insulin resistance, hypertension, bone loss, mood disorders, and cardiovascular risk; balanced values support recovery, cognition, and long-term metabolic health.
Reading the Cortisol-to-DHEA-S Ratio
There is no universal reference interval; labs use age- and time-of-day–specific morning ranges. In general, values near the middle of a lab's morning, age‑adjusted range are considered balanced. Children and teens often run lower ratios during adrenarche and puberty; the ratio tends to rise with aging. Pregnancy commonly shifts the ratio higher due to physiologic increases in cortisol.
When the ratio trends low, it usually means cortisol output is relatively modest or DHEA-S is comparatively high. Physiology tilts toward less glucose production and vascular tone, with more androgen signaling. People may notice morning fatigue, lightheadedness, or "crash" after stress; if driven by high DHEA-S, women may see acne, oily skin, or cycle irregularity, while teens often show this pattern as a normal pubertal variant. This can signal reduced capacity to mount a stress response, with fatigue, lightheadedness, and low fasting glucose risk, while favoring androgen effects. Congenital adrenal enzyme defects are a rare cause.
Being in range suggests balanced HPA signaling with adaptable energy use, stable glucose and blood pressure, resilient mood and cognition, and moderated immune activity. For most adults, within reference ranges tends to fall in the mid-range for age and sex when sampled in the morning.
When the ratio is high, cortisol dominates. This pattern aligns with chronic stress physiology and aging: poorer sleep, central weight gain, elevated blood pressure or glucose, reduced muscle and bone strength, more infections, and low mood or brain fog. In women, low libido and menstrual disruption may appear. Ratios rise with aging as DHEA-S declines, and can be markedly high in Cushing physiology or with glucocorticoid use. In pregnancy, total cortisol increases and the ratio is typically higher.
What Can Shift the Cortisol-to-DHEA-S Reading
Notes: Interpret by time of day (morning preferred for consistency). Acute illness, surgery, and strenuous exercise raise cortisol. Estrogens, pregnancy, and oral contraceptives increase cortisol-binding proteins. DHEA-S falls with age and differs by sex. Assay methods vary; consider the absolute hormones alongside the ratio.
FAQs
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Erceg, N., Micic, M., Forouzan, E., & Knezevic, N. N. (2025). The role of cortisol and dehydroepiandrosterone in obesity, pain, and aging. Diseases, 13(2), 42. https://doi.org/10.3390/diseases13020042
- Dharia, S., & Parker, C. R. (2004). Adrenal androgens and aging. Seminars in Reproductive Medicine, 22(4), 361-368. https://doi.org/10.1055/s-2004-861552
- Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., & Torpy, D. J. (2016). Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 101(2), 364-389. https://doi.org/10.1210/jc.2015-1710
- Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576-590. https://doi.org/10.1038/s41574-018-0059-4
- Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007). Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement. The Journal of Clinical Endocrinology & Metabolism, 92(2), 405-413. https://doi.org/10.1210/jc.2006-1864






































.avif)
